IMPORTANCE New genomic strategies can now be applied to identify a diagnosis in patients and families with previously undiagnosed rare genetic conditions. The large family evaluated in the present study was described in 1966 and now expands the phenotype of a known neuromuscular gene.
1
Neurogenic disorders can also be present in a scapuloperoneal distribution as seen with some TRPV4 (OMIM 605427) mutations. 2 In 1966, Armstrong and colleagues 3 reported on 2 individuals from a family with a dominantly inherited phenotype of early onset, predominantly scapuloperoneal muscle weakness. The disorder was classified as proximal spinal muscular atrophy on the basis of biopsy and electromyographic findings interpreted as neurogenic changes. The family returned for further evaluation of 14 patients from an expanded 6-generation pedigree with 33 known affected individuals who presented with scapulohumeroperoneal weakness as well as distal hand and mild facial involvement.
The disease was progressive but of highly variable severity in the family. Linkage analysis combined with exome sequencing revealed a novel mutation in ACTA1 (OMIM 102610) in a highly conserved residue, which cosegregated with the clinical phenotype. The actinopathies are caused by mutations in skeletal muscle actin encoded by ACTA1. They cover a heterogeneous spectrum of clinical severity and histomorphologic expression, [4] [5] [6] including nemaline myopathy, intranuclear rod myopathy, rod-core myopathy, actin aggregation, zebra bodies, and fiber-type disproportion. 5, 7 The ACTA1-related scapuloperoneal myopathy without nemaline rods or actin accumulations reported in this family does not belong to any of the hitherto recognized clinicopathologic actinopathies and thus expands the phenotypic range of actinopathies.
Methods
In this observational study, we examined 14 affected individuals from a 6-generation pedigree. The study was conducted from March 1, 2005 , to May 31, 2014. The institutional review board of the National Institute of Neurological Disorders and Stroke approved the study. Written informed consent was obtained from all participants, who received financial compensation. Patient consent-to-disclose forms included consent for publication and were obtained for all photos and videos.
Neurologic Examination
A comprehensive neurologic examination was performed. A summary of the findings of the examination is presented in the Table. Muscle Biopsy and Immunochemistry
Histochemical stains, including hematoxylin-eosin, Gomori-trichrome, and nicotinamide adenine dinucleotide tetrazolium reductase, were performed on 9-μm frozen muscle samples. For immunohistochemical analysis, sections and cells were fixed in 4% para-formaldehyde, blocked in 0.1% Tx-100/ 10% fetal bovine serum/phosphate-buffered saline, 
Muscle Ultrasonography
Skeletal muscle ultrasonography was performed using an L12-5 linear transducer at 12 MHz on a Philips iu22 system. Muscles of the thigh, calf, and proximal arm were imaged.
Motor Unit Number Estimation
The estimated number of motor units innervating hypothenar muscles (motor unit number estimation [MUNE]) was based on published 8 multiple-point stimulation techniques (Teca Synergy N-EP machine; Cardinal Health). The MUNE value was calculated by dividing the maximum compound muscle action potential negative peak amplitude by the mean surface motor unit potential negative peak amplitude. In addition, conventional nerve conduction studies and electromyography (Nicolet) were performed on one patient (IV-25).
Linkage Analysis
Genotyping was performed using Illumina Linkage IV Panel, which includes 5861 informative single-nucleotide polymorphism (SNP) markers distributed evenly across the human genome at an average distance of 0.64 centimorgans. The SNP data were analyzed using Merlin 9 linkage software, version 1.1.2, assuming a fully penetrant dominant model of disease transmission.
Exome Sequencing
The DNA from affected individuals IV-23, IV-25, V-6, V-8, V-10, V-11, and VI-9 was enriched (SureSelect Exome target enrichment, version 1.0; Agilent Technologies). The enriched DNA was paired-end sequenced (Genome Analyzer IIx; Illumina). Sequence alignment and variant calling were performed using Burrows-Wheeler Aligner, 10 the Genome Analysis Toolkit, 11, 12 and Picard (http://picard.sourceforge.net/index.shtml). The Burrows-Wheeler Aligner was used to align the paired-end sequence against the reference human genome (UCSC hg18). The Genome Analysis Toolkit was used to recalibrate quality scores, perform local realignments around insertions and deletions, identify variants, and call genotypes. Polymerase chain reaction duplicates were removed using Picard prior to variant calling with the Genome Analysis Toolkit. Based on the hypothesis that the mutation underlying this rare familial disease was not present in the general population, SNPs identified in the 1000 Genomes project (http://www.1000genomes.org/) or in dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP, Build 131) were removed. We excluded variants that were not shared by all patients. Next, synonymous changes were identified and filtered from the variant list using SIFT, version 4.0 (http://sift .jcvi.org/). 
Molecular Modeling
The high-resolution crystal structure of human actin (pdb-code: 3DAW; sequence identity: 100%) was used as a modeling template. 13 The implemented single-point mutation of glutamic acid (Glu)197 to aspartic acid (Asp)197 was subject to gradient energy minimization in the Crystallography and NMR system. 14 The lowest energy structures of the single-point mutant version were subject to 500 cycles of unrestrained Powell minimization. Harmonic restraints were imposed on the target molecule (2 kcal/mol Å 2 ) with increased weight (25 kcal/ mol Å 2 ). Protein structure and model assessment tools were used to verify the quality of the modeled structure.
Transfection and Western Blotting
Cos-7 cells were transfected with WT-eGFP, Asp286Gly-eGFP, and Asp197Glu-eGFP constructs (Lipofectamine; Invitrogen). Immunochemical analysis was performed as described above. For the Western blot, primary antibody to α1 actin (Sigma) and secondary goat antimouse IgG-horseradish peroxidase was used. Proteins were resolved by electrophoresis on a 4% to 12% gradient Bis-Tris polyacrylamide gel and blotted according to a standard protocol.
Zebrafish Studies
Wild-type and Glu197Asp human ACTA1 genes were cloned into pCSDest vector (Addgene) as described. 15 Plasmids were linearized with restriction enzyme NotI, and RNA was transcribed using a kit (SP6 mMessage Machine kit; Ambion). Onecell stage embryos were injected with 200 pg and 400 pg of RNA, and muscle was analyzed as described previously 16 using Acti-stain 670 (Cytoskeleton Inc) and antimyosin heavy chain antibody (F59; Santa Cruz Biotech).
Results

Clinical Findings
We examined 14 patients from an expanded 6-generation pedigree, in which 33 individuals are known to be affected ( Figure 1 ).
Muscle weakness was noted in both the lower and upper extremities. The lower extremities exhibited an initial pattern of distal, more than proximal, involvement with early foot drop, but proximal involvement became more pronounced with age. The overall distribution of muscle involvement was scapulohumeral-peroneal with additional hand involvement. Early scapular winging ( Figure 2 , patients VI-2 and VI-5), muscle atrophy of the thenar and deltoid muscles ( Figure 2 , patient V-6), and mild lower facial weakness ( Figure 2 , patient IV-23) were typical. Hand involvement was particularly notable, including wrist and finger drop (in particular, digits 3-5). Affected individuals developed contractures of the Achilles tendon, elbow, and shoulder. Deep tendon reflexes were diminished or absent. Phenotypic variability was evident in that more severely affected patients presented with hypotonia, foot eversion, and dorsiflexion weakness from infancy ( Figure 2 , patient V-6), with a "notch" in the shoulder muscle noted by their parents. Running in childhood was awkward, followed by progressive weakness resulting in loss of independent ambulation and development of scoliosis in the fifth or sixth decade of life (III-4, III-7, and III-9). In the most severely affected patients (IV-23 and VI-2), marked weakness and atrophy were especially apparent in the upper extremities, with no remaining antigravity strength in the proximal and shoulder muscles, even while still ambulant. For example, at age 15 years, this was evident in patient VI-2 (Video 1 and Video 2), and patient IV-23 was initially able to walk short distances, but the condition progressed to loss of ambulation. One of the youngest patients (VI-5), examined at age 9 years, showed less severe weakness in a similar pattern, consistent with the slowly progressive nature of the disease. Other affected individuals did not note weakness until early adulthood. Detailed findings are listed in the Table. Muscle Imaging
On muscle ultrasonography, findings were variable, although atrophy was apparent in all patients. Advanced muscle involvement with uniform increase in echogenicity in patient IV-23 is shown in eFigure 1 in the Supplement. In patient V-6, An extensive pedigree of the family with the novel ACTA1 mutation depicting affected members in each generation, with a total of 33 known affected individuals. Circles indicate female; squares, male. The numbers within triangles indicate the number of additional children (not all unaffected children were drawn out individually).
a mixed granular and streaklike pattern was observed (eFigure 1 in the Supplement). Muscle magnetic resonance imaging was performed on patients IV-23 and V-6. Patient IV-23 showed marked atrophy, as well as significant fatty replacement of the quadriceps and, in particular, of the vastus intermedius and the rectus femoris; the hamstring muscles also demonstrated severe involvement with some notable sparing of parts of the semitendinosus and adductor longus muscles (eFigure 1 in the Supplement). In contrast, patient V-6 was more mildly affected, with minimal involvement of the sartorius, biceps femoris, and vastus lateralis (eFigure 1 in the Supplement).
Histopathologic Findings
Muscle biopsies from patients IV-23, IV-27, and V-6 ( Figure 3 ) demonstrated variability of histologic findings, suggesting progression with age. The muscle in patient IV-23 was initially biopsied in childhood and, as reported in the original article, 3 showed groups of atrophic fibers. The more recent muscle biopsy in this patient, obtained from the tibialis anterior, demonstrated end-stage muscle with marked degenerative features including dramatic variability in fiber size (with atrophic and hypertrophic fibers), greatly increased internalization of nuclei, and fatty infiltration. On nicotinamide adenine dinucleotide stain, frequent trabeculated or lobulated fibers were noted (Figure 3 ). In contrast, muscle biopsies from the less affected patients (IV-27 and V-6) indicated milder changes, although groups of atrophic fibers of type I were present, consistent with fiber-type disproportion. None of the muscle biopsies revealed nemaline rods on modified Gomoritrichrome stain or electron microscopy or actin aggregates by immunohistochemistry or electron microscopy ( Figure 3 , eFigure 2 in the Supplement). The nNOS staining was robust in the atrophic fibers, arguing against denervation as a cause for the atrophy (eFigure 3 in the Supplement).
MUNE Results
For patient VI-2, the compound muscle action potential amplitude of the right ulnar nerve was 7005 μV, and the mean surface motor unit potential was 119 μV. The MUNE of the right ulnar nerve was 59. For unaffected relative VI-8, the compound muscle action potential amplitude of the right ulnar nerve was 10 773 μV, and mean surface motor unit potential was 57 μV. The MUNE of the right ulnar nerve was 189. Results of nerve conduction studies of the right arm and leg of one later affected family member (IV-25) were normal.
Electromyography of the right side demonstrated large polyphasic motor units with delayed recruitment, especially in weaker muscles (knee extensors), but occasional smallamplitude, polyphasic motor units were also observed in less affected muscles (deltoid). No abnormal spontaneous activity was observed. that, on NADH stain, were dark and thus were type I. Patient V-6's biopsy (biceps) revealed variability in fiber size with groups of atrophic fibers and some degree of central nucleation (G); on NADH staining, the small fibers were dark, again indicating fiber type I atrophy (H). Ultrastructural examination in patient IV-23 demonstrated disrupted myofibrils in severely atrophic fibers but no rod formation (C), whereas patients IV-27 and V-6 had normally aligned Z-discs and no evidence of rod formation (F and I).
Genetic Analysis
Structural Modeling and Interpretation
Monomeric actin can oligomerize into double-stranded F-actin trimers. In the trimer, which represents a minimal F-actin filament seed, Glu197 is a critical semisurfaceexposed residue that is involved in 2 major interaction sites ( Figure 4) . The glutamic moiety forms a network of 2 shortrange intramolecular interactions mediating a spatial bridging of lysine (Lys)193 and arginine (Arg)258 (Figure 4 ). However, Glu197 is in medium-range distance to the basic charged side chain of Lys115, forming an electrostatic interaction between 2 neighboring actin subunits at the fast-growing barbed end of the F-actin filament ( Figure 4C ). Our modeling approach revealed a significant effect of the single-point mutation Glu197Asp. Shortening of the acidic side chain by a single methylene unit causes a seriously diminished radius of action ( Figure 4C ), with dramatic effects on both intramolecular and intermolecular interactions. Asp197 is not able to establish the intermolecular salt bridge with Lys115 from the longitudinal subunit. In addition, Arg258 is not engaged in an electrostatic interaction with Asp197. Instead, the carboxylic moiety of Asp197 is forming a singular salt bridge with Lys193.
Functional Analysis
To determine whether the Glu197Asp mutation can lead to rod formation, Cos-7 cells were transfected with WT-eGFP, Asp286Gly-eGFP, and Glu197Asp-eGFP constructs. The Asp286Gly-eGFP construct was used as a positive disease control that was known to form nemaline rods after transfection in culture; a mock transfection was used as a negative control. Neither immunostaining nor Western blot showed any significant changes in actin localization between the Glu197Asp-eGFP construct and WT-eGFP, whereas the positive disease control resulted in rod formation as expected and previously reported 17 (eFigure 5 in the Supplement). However, no intranuclear rods were seen. The constructs were also transfected into HEK, NIH3T3, and C2C12 cells, none of which showed a phenotype of rod formation or abnormalities of the actin skeleton at 24, 48, 72, 96, or 120 hours (eFigure 6 in the Supplement). In addition, zebrafish injected with RNA encoding either wild type or Glu197Asp human ACTA1 displayed no abnormalities in their morphology or muscle histology up to 6 days after fertilization, including no actin accumulations or sarcomeric disorganization (eFigure 7 in the Supplement).
Discussion
In this study, we identified a novel variant in ACTA1 associated with scapuloperoneal myopathy in a multigenerational family with a phenotype different from that of previously as having a form of proximal or scapuloperoneal spinal muscular atrophy. We reevaluated 14 of the 33 patients from 4 of 6 generations known to be affected. The core clinical phenotype, present in affected family members, manifested as early as infancy with a predominantly scapuloperoneal, but more precisely scapulo-humeralperoneal-distal, distribution of weakness with scapular winging. Over time, the muscle weakness progressed to other proximal muscle groups. Shared clinical characteristics included mild lower facial weakness, foot drop due to foot eversion and dorsiflexion weakness, finger drop of digits 3 to 5, and selective muscle atrophy. We recognized significant variability between family members regarding age of onset and severity. Some patients had onset in early childhood and were severely affected by their teenage years (VI-2); others did not experience an onset of weakness until their teenage years or adulthood (V-6 and IV-32). Some of the patients were significantly more affected in the upper limbs (VI-6 and IV-23); others were more equally affected in their lower limbs and lost ambulation (IV-25). This variability does not seem to segregate with sex or among distinct branches in the family tree but suggests that genetic modifiers may play a role. There was no evidence for cardiac, early respiratory, or extraocular muscle involvement.
The have observed loss of motor units in muscular dystrophies and chronic myopathies with mixed myopathic and neurogenic features on electromyography. Thus, we suspect the striking muscle fiber atrophy observed in this family accounts for the "pseudoneurogenic" findings on biopsy and electrophysiologic testing. The fact that we found that atrophic fibers were not nNOS deficient also argues in favor of a myopathic rather than neurogenic origin. We applied a combined linkage/whole-exome sequencing approach, which is particularly powerful in large multiplex families such as this one. This strategy resulted in a significantly linked 4.8-megabase region on chromosome 1, in which only the variant p.Glu197Asp in ACTA1 qualified as pathogenic. This variant segregated perfectly with disease manifestation throughout the extended family.
Because ACTA1 is one of the most highly conserved genes in muscle, it does not generally tolerate missense changes. Most amino acid sequence-changing variants recognized in ACTA1 have thus far been pathogenic with primarily a dominant mode of action, while most recognized polymorphic sequence variants in the gene are synonymous on the amino acid level. 20 Compared with the known clinicopathologic entities within the actinopathies, the family reported here is different clinically as well as morphologically. Typical findings on muscle biopsy vary among actinopathies, and previous reports 26-28 include cytoplasmic and/or intranuclear nemaline rods, actin aggregates, fiber-type disproportion, and zebra body formation. Muscle biopsy specimens in this family notably showed no nemaline rods, even in advanced stages of the disease. Although the fiber-type disproportion observed in our family has been observed 22 in ACTA1 mutations as part of the possible histologic spectrum, lobulated or trabeculated fibers, as seen in the more advanced biopsy, have not been reported in patients with actinopathy. However, this cytoarchitectonic abnormality is not specific in itself and has been described in a few other cases of muscular diseases.
29-31
Mutations in the ACTA1 residue Glu197 have not been previously reported, 5 but mutations in adjacent residues have been shown to be pathogenic: Thr196Pro and Arg198Cys both result in a severe nemaline myopathy.
32
Evaluation of the pathogenicity of Glu197Asp by PolyPhen-2 and SIFT (amino acid change prediction website: http://sift .jcvi.org) predicts a relatively mild change consistent with the comparatively less severe and unusual phenotype displayed in this family. Localization of this residue on the 3-dimensional model of actin shows it is located on the exterior surface of the protein. Further modeling of the mutation reveals it to significantly affect both short-range intramolecular interactions with Lys193 and Arg258 and medium-range intermolecular electrostatic interactions with Lys115 on neighboring actin subunits. The interacting Arg258 (labeled in reference as Arg256) has been shown 21 to be involved in a severe nemaline myopathy. To further study the functional consequences of the mutation, mutation constructs were tested in various cell types. In contrast to the nemaline rod formation seen after transfection of a typical nemaline myopathy-associated mutation, 33 no apparent change in actin cytoarchitecture or rod formation was observed with Glu197Asp, nor were any effects on the protein level noted. In addition, injection of Glu197Asp RNA into zebrafish embryos did not result in whole-mount morphologic abnormalities. It is therefore possible that the Glu197Asp mutation may instead reflect a fundamentally different pathogenesis, such as changes in interaction or force generation, actin filament stability, or differences in the directionality of actin filament growth, for which further investigation is necessary and underway.
